← Leaderboards
Mehrdad Shamloo
Stanford University
$9,890,326
Attributed
$14,123,223
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2011–25$2.5M$1.9M$1.3M$625K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,123,223 · 10
By mechanism
U24$5,191,106 · 1
R01$2,425,566 · 1
P30$2,358,045 · 2
UH3$1,621,997 · 1
R21$879,972 · 2
S10$742,686 · 1
Top collaborators
- William T Newsome4 shared
- Sergiu Pasca4 shared
- Gordon X Wang4 shared
- Annelise Emily Barron1 shared
- Laren Becker1 shared
Most similar at Stanford University
Same institution · by research overlap
- Sergiu Pasca$19,655,599
- Alison R. Preston$9,233,890
- Fikri Birey$2,453,201
- Jin Hyung Lee$23,923,667
- Jan E Carette$15,833,982
Others in their field
Top investigators on “Behavior”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Lawrence Corey · Fred Hutchinson Cancer Center$316,652,479
- Chanza Baytop · Westat, Inc.$271,217,917
- Everette D Joseph · Howard University$243,972,016
- Eric J Barron · Pennsylvania State Univ University Park$243,972,016
Research focus
BehaviorIn VivoBehavioralRodentAlzheimer&AposBrainPhenotypeBaseResearch PersonnelSignal TransductionCellsInnovationTransgenic OrganismsTechnologyPharmacologyLearningMemoryLaboratoriesMolecularPlayCommunitiesAnimalsResourcesNeurons
Grant awards (27)
A Shared Neuroscience Platform for National Dissemination and Training in Brain Organogenesis, Behavioral and Brain Disease Models, Viral Vectors, and Imaging Technologies$1,253,014
U24 · FY2025 · NS · contact PI
Development of selective cannabinoid receptor 2 agonists for treatment of addiction$334,044
UH3 · FY2025 · NS · contact PI
A Shared Neuroscience Platform for National Dissemination and Training in Brain Organogenesis, Behavioral and Brain Disease Models, Viral Vectors, and Imaging Technologies$1,216,033
U24 · FY2024 · NS · contact PI
Development of selective cannabinoid receptor 2 agonists for treatment of addiction$658,362
UH3 · FY2024 · NS · contact PI
A Shared Neuroscience Platform for National Dissemination and Training in Brain Organogenesis, Behavioral and Brain Disease Models, Viral Vectors, and Imaging Technologies$1,363,360
U24 · FY2023 · NS · contact PI
Development of selective cannabinoid receptor 2 agonists for treatment of addiction$629,591
UH3 · FY2023 · NS · contact PI
A Shared Neuroscience Platform for National Dissemination and Training in Brain Organogenesis, Behavioral and Brain Disease Models, Viral Vectors, and Imaging Technologies$1,358,699
U24 · FY2022 · NS · contact PI
Development of selective cannabinoid receptor 2 agonists for treatment of addiction$661,980
UG3 · FY2022 · NS · contact PI
Common CD36-dependent gut-brain neuroimmune pathway regulates disruption of intestinal motility in Alzheimer's Disease$437,265
R21 · FY2022 · AG
Animal Research Equipment, Digital Cages & Metabolic, Avoidance, Fear Conditioning, Place Preference, Self-Administration, Open Field, & Microdialysis Systems for Translational Neuroscience$742,686
S10 · FY2021 · OD · contact PI
Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease$452,916
R01 · FY2021 · AG · contact PI
Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease$471,277
R01 · FY2020 · AG · contact PI
Validation and pharmacological profiling of a non-psychoactive THC analog, a novel and selective CB2 receptor agonist, in proof of concept studies using rodent models of heroin addiction$241,871
U18 · FY2020 · DA · contact PI
Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease$486,895
R01 · FY2019 · AG · contact PI
Behavioral and Functional Neuroscience Laboratory$221,870
P30 · FY2019 · NS · contact PI
Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease$503,467
R01 · FY2018 · AG · contact PI
Behavioral and Functional Neuroscience Laboratory$223,746
P30 · FY2018 · NS · contact PI
Role of beta-adrenergic receptors in modulation of cognition and central and peripheral immune systems in Alzheimer's disease$511,011
R01 · FY2017 · AG · contact PI
Behavioral and Functional Neuroscience Laboratory$226,106
P30 · FY2017 · NS · contact PI
Role of beta adrenergic receptors in modulation of cognition, pathology and neuroinflammation in Alzheimer's Disease$199,493
R21 · FY2017 · NS · contact PI
Role of beta adrenergic receptors in modulation of cognition, pathology and neuroinflammation in Alzheimer's Disease$243,214
R21 · FY2016 · NS · contact PI
Behavioral and Functional Neuroscience Laboratory$222,778
P30 · FY2016 · NS · contact PI
BEHAVIORAL CORE$278,648
P30 · FY2015 · NS · contact PI
BEHAVIORAL CORE$272,316
P30 · FY2014 · NS · contact PI
BEHAVIORAL CORE$320,085
P30 · FY2013 · NS · contact PI
BEHAVIORAL CORE$351,221
P30 · FY2012 · NS · contact PI
BEHAVIORAL CORE$241,275
P30 · FY2011 · NS · contact PI